Featured
Last news
A Co-Founder of Athos Therapeutics, Dr. Michael E. Jung, Wins the National Academy of Sciences Award for Chemistry in Service to Society
LOS ANGELES, CA / ACCESS Newswire / April 30, 2025 / Athos Therapeutics, Inc. ("Athos"), a clinical stage biotechnology company pioneering the development of precision small molecule therapeutics for patients with immune-mediated diseases, is honored to announce that Dr. Michael E. Jung, a co-founder of Athos, was awarded the National Academy of Sciences Award for Chemistry in Service to Society.
Greenlite Ventures Launches Revolutionary AI-Powered NBA Daily Fantasy Sports Platform
LOS ANGELES, CALIFORNIA / ACCESS Newswire / April 30, 2025 / Greenlite Ventures, Inc. (OTC PINK:GRNL), an emerging innovator at the intersection of sports, gaming, and technology, is proud to announce the official launch of its cutting-edge NBA Daily Fantasy Sports (DFS). The platform is now live and available to users across the United States and globally, ushering in a new era of fantasy sports where artificial intelligence empowers player decisions like never before. In the United States, the NBA DFS platform will initially operate as a free-to-play experience, later enabling real-money gameplay in jurisdictions where wagering is permitted. This hybrid model ensures full compliance with state-by-state laws while offering maximum accessibility for basketball fans nationwide.
General Assembly of the Critical Infrastructure Association of the Slovak Republic Sets Future Direction
BRATISLAVA, SK / ACCESS Newswire / April 30, 2025 / The General Assembly of the Critical Infrastructure Association of the Slovak Republic took place in Bratislava, attended by key experts and representatives of companies operating in the field of critical infrastructure protection. The main agenda items included the election of association bodies, admission of new members, and discussion about the strategic direction of the association's activities.
Study sheds light on origin of Australia's odd echidna
Australia's burrowing echidna evolved from a water-dwelling ancestor in an "extremely rare" biological event, scientists said Tuesday in a new study of the peculiar egg-laying mammals.
Less-thirsty rice offers hope in drought-stricken Chile
A cold, dry part of Chile might not sound like the best place to grow rice, a famously thirsty grain that thrives in tropical conditions.
Mynaric Announces Peter Müller-Brühl as New Chair of Supervisory Board
Peter Müller-Brühl elected Chair of Mynaric’s Supervisory Board, with Dr Manfred Krischke elected Vice-Chair
Amaze Expands Creator Ecosystem Through Exclusive Partnership with Live Current Media
Deal Unlocks New Streaming Capabilities Expected to Attract New Creators
Scipher Medicine and InnoSIGN Announce Partnership to Advance Precision Medicine in Immunology
Collaboration combines Scipher's unique RNAseq data, part of the largest non-oncology clinico-transcriptomic data lake and biobank, with InnoSIGN's proprietary Comprehensive Pathway Analysis (CPA) platform to enhance the understanding of complex immune-mediated diseases.
Suministros & Alimentos Optimizing the Food Industry Supply Chain with ToolsGroup at the Gartner(R) Supply Chain Symposium/XPO(TM) 2025
Next generation prediction algorithms excel at preventing business disruption and optimizing the supply chain for Central American food distribution logistics
MicroVision Establishes Defense Industry Advisory Board
REDMOND, WA / ACCESS Newswire / April 29, 2025 / MicroVision, Inc. (NASDAQ:MVIS), a technology pioneer delivering advanced perception solutions in autonomy and mobility, today announced that it has formed a Defense Advisory Board to further the company's strategic expansion, pursuing customer and partnership opportunities to deliver MicroVision's leading technologies and safety solutions into the defense tech industry and military sector.
Paragon Technologies Responds to Board Nominations by Former CEO Sham Gad
Details Audit Committee's Findings of Gad's Pattern of Deceit and Misuse of Corporate Assets
CORRECTION FROM SOURCE: Upexi Purchases 45,733 Solana Tokens as it Begins Deploying $100 Million Treasury in Solana Strategy
Correcting the participants in the $100 million private placement.Since the closing of Upexi's $100 million private placement, the Company has accumulated approximately 45,733 Solana tokens for approximately $6.7 million
Altigen Technologies Reports Second Quarter Results for Fiscal Year 2025
NEWARK, CA / ACCESS Newswire / April 29, 2025 / Altigen Technologies (OTCQB:ATGN), a leading Silicon Valley-based Microsoft Cloud Communications Solutions provider, announced today its financial results for the second quarter ended March 31, 2025.
The Q1 Form 941 Deadline is Here! TaxBandits Offers a Reliable Solution for Last-Minute Filing
Businesses and tax professionals can meet the April 30, 2025 Form 941 deadline easily with TaxBandits' simplified filing, Ready Return, and exclusive savings.
Introducing the AI Formula Generator by involve.me: Advanced Funnel Calculations in Seconds
VIENNA, AUSTRIA / ACCESS Newswire / April 29, 2025 / involve.me, a leading no-code funnel builder for creating engaging and conversion-driven funnels, has announced its latest feature: the AI Formula Generator. Designed to simplify complex calculations within funnels, this new AI-powered tool empowers users to enhance their lead generation and customer engagement efforts.
VueReal Expands Reference Design Kit Portfolio with Industry-Specific Bundles to Accelerate MicroLED Commercialization
MicroSolid Printing(TM) Platform Powers New Automotive and Consumer Electronics Bundles Debuting at Display Week 2025
Paragon Announces Settlement with Hesham M. Gad, Litigation Dismissed
EASTON, PA / ACCESS Newswire / April 29, 2025 / Paragon Technologies, Inc. (OTC PINK:PGNT) ("Paragon") today announced that it has reached a settlement agreement with Hesham M. Gad with respect to the ongoing litigation and other related matters. Pursuant to the agreement, Mr. Gad has agreed to dismiss his claims against directors Samuel S. Weiser, Jack H. Jacobs, H. Timothy Eriksen, David Lontini, and Howard Brownstein, and Paragon has concurrently agreed to dismiss its counterclaims against Mr. Gad.
BluStream Doubles Its User Base and Appoints VP of Product Marketing as Demand Accelerates for Its Product Experience AI Solutions
Growth Signals the Importance of Hyper-Personalized Experience Solutions to Help Brands Maintain Meaningful Connections with Customers
SMC Entertainment Launches Plato's Web3 Browser, Enabling Secure Access to Multiple Decentralized Applications
BOCA RATON, FL / ACCESS Newswire / April 29, 2025 / SMC Entertainment, Inc. ("SMC" or the "Company") (OTC PINK:SMCE), a Fintech incubator company focused on acquisition and support of commercialized financial services and technology (Fintech) companies, is pleased to announce that it has entered into a technology deployment agreement ("Deployment Agreement") with Plato Technologies Inc. ("Plato").
Weiser Announces Departure from Paragon Board at Upcoming Annual Meeting
EASTON, PA / ACCESS Newswire / April 29, 2025 / Paragon Technologies, Inc. (OTC Pink:PGNT), a diversified holding company, today announced that Samuel S. Weiser, the current Interim CEO and Director since 2012, has notified the Nominating and Governance Committee of Paragon's Board of Directors that he will not stand for re-election at the upcoming Annual Meeting of Shareholders.
Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms
Company's AI and Big Data technology positioned to drive strong industry collaborationCompany also announces certain corporate actions
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology
LAS VEGAS, NEVADA / ACCESS Newswire / April 29, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that The Center for Devices and Radiological Health of the U.S. Food and Drug Administration (FDA) has received the company's submission package requesting a pre-submission meeting with the FDA for its VisionAI platform technology and is now under review.
Netlist Schedules First Quarter 2025 Financial Results and Conference Call
IRVINE, CA / ACCESS Newswire / April 29, 2025 / Netlist, Inc. (OTCQB:NLST) announced today that it will report its financial results for the first quarter ended March 29, 2025, before 9:30 a.m. Eastern Time on Tuesday, May 6, 2025.
Intrusion Inc. Reports First Quarter 2025 Results
Company continues to make steady progress toward sustainable growth and profitability
Amazon launches first Starlink-rival internet satellites
Amazon on Monday launched its first batch of Project Kuiper internet satellites, marking the start of its push to rival Elon Musk's Starlink.
Amazon set for launch of Starlink-rival satellites
After delaying an earlier attempt due to bad weather, Amazon is preparing to launch its first batch of Project Kuiper internet satellites on Monday, stepping into direct competition with Elon Musk's Starlink.
Smart driving new front in China car wars despite fatal crash
Intelligent driving features are the new battleground in China's merciless car market, with competition spurring brands to world-leading advances -- but a recent fatal crash has seen the government intervene to put the brakes on runaway enthusiasm.
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
SOLANA BEACH, CA / ACCESS Newswire / April 28, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, announces that today its partner, Clinical Laserthermia Systems AB (publ) (CLS), completed the submission of its 510(k) application to the FDA, expanding the indication of the ClearPoint Prism Neuro Laser Therapy System to include 1.5 T MRI guidance.
Living Security's Unify Platform Just Got Smarter-3X More Visibility, Zero Blind Spots, and AI-Powered Adaptive Intelligence That Connects Your Siloed Security Data
AUSTIN, TX / ACCESS Newswire / April 28, 2025 / Living Security, the global leader in human risk defense, today unveils powerful adaptive intelligence capabilities within its Unify platform. By fusing human expertise from its Human Intelligence Team (HInT), advanced AI phishing simulations, and industry-wide threat telemetry, Unify now delivers a minimum of 3X more visibility into human risk compared to outdated security awareness tools. This advancement is validated by third-party research from Cyentia.
Ondas Secures $3.4 Million Order for Iron Drone Raider Counter-UAS System from Renowned European Defense Contractor for Government Client
Initial order in Europe highlights Ondas' continued momentum as an emerging defense technology prime contractor, delivering next-generation autonomous systems to address evolving aerial threats and support critical national security operationsThis latest purchase order builds on a series of international contracts and operational milestones, reinforcing the Company's rapid growth and expanding presence in defense and security markets
Tharimmune Advances TH104 for Prophylaxis Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback
BRIDGEWATER, NEW JERSEY / ACCESS Newswire / April 28, 2025 / Tharimmune, Inc., (Nasdaq:THAR) ("Tharimmune" or the "Company") a clinical-stage biopharmaceutical company focused on developing innovative therapeutics in inflammation & immunology, recently announced positive feedback from the U.S. Food and Drug Administration (FDA) regarding TH104. The agency confirmed that no additional clinical trials appear to be necessary prior to a 505(b)(2) New Drug Application (NDA) submission. TH104 is a buccal film formulation, of nalmefene specifically designed for rapid absorption with a potential for bypassing liver metabolism. This allows TH104 to be suitable for the temporary prophylaxis of respiratory and/or nervous system depression in military personnel and chemical incident responders who may be exposed to high-potency opioids, including weaponized fentanyl and its analogues.
Global Interactive Technologies, Inc. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq
SEOUL, KOREA / ACCESS Newswire / April 28, 2025 / Global Interactive Technologies, Inc. (NASDAQ:GITS) (the "Company"), announced that on April 24, 2025, it received a delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising the Company that due to the Company's failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2024 with the Securities and Exchange Commission (the "SEC"), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports with the SEC.